Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz,Carolina Alcantara Hirsch,Tanner Dalton,Sorin Alberto Shadaloey,Alireza Khodadadi-Jamayran,George Miller,Sumedha Pareek,Hajar Rajaei,Chirayu Mohindroo,Seyda Baydogan,An Ngo-Huang,Nathan Parker,Matthew H G Katz,Maria Petzel,Emily Vucic,Florencia McAllister,Keri Schadler,Rafael Winograd,Dafna Bar-Sagi
DOI: https://doi.org/10.1016/j.ccell.2022.05.006
IF: 50.3
2022-07-11
Cancer Cell
Abstract:Aerobic exercise is associated with decreased cancer incidence and cancer-associated mortality. However, little is known about the effects of exercise on pancreatic ductal adenocarcinoma (PDA), a disease for which current therapeutic options are limited. Herein, we show that aerobic exercise reduces PDA tumor growth, by modulating systemic and intra-tumoral immunity. Mechanistically, exercise promotes immune mobilization and accumulation of tumor-infiltrating IL15Rα+ CD8 T cells, which are responsible for the tumor-protective effects. In clinical samples, an exercise-dependent increase of intra-tumoral CD8 T cells is also observed. Underscoring the translational potential of the interleukin (IL)-15/IL-15Rα axis, IL-15 super-agonist (NIZ985) treatment attenuates tumor growth, prolongs survival, and enhances sensitivity to chemotherapy. Finally, exercise or NIZ985 both sensitize pancreatic tumors to αPD-1, with improved anti-tumor and survival benefits. Collectively, our findings highlight the therapeutic potential of an exercise-oncology axis and identify IL-15 activation as a promising treatment strategy for this deadly disease.